These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17033395)

  • 21. Infection with Chlamydia pneumoniae and atherosclerosis: a review.
    Movahed MR
    J S C Med Assoc; 1999 Aug; 95(8):303-8. PubMed ID: 10478518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Chlamydia pneumoniae and atherosclerotic lesions.
    Phillips JI; Shor A
    Cardiovasc J S Afr; 2001; 12(1):42-6. PubMed ID: 11447492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease.
    Maass M; Bartels C; Krüger S; Krause E; Engel PM; Dalhoff K
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S25-30. PubMed ID: 9859922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of Chlamydia pneumoniae and atherosclerosis.
    Lindholt JS; Fasting H; Henneberg EW; Ostergaard L
    Eur J Vasc Endovasc Surg; 1999 Apr; 17(4):283-9. PubMed ID: 10204048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Chlamydia pneumoniae in arterial tissues.
    Kuo C; Campbell LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S432-6. PubMed ID: 10839731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen.
    Jackson LA; Campbell LA; Kuo CC; Rodriguez DI; Lee A; Grayston JT
    J Infect Dis; 1997 Jul; 176(1):292-5. PubMed ID: 9207386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications?
    Zamorano J; García-Tejada J; Suárez A; Culebras E; Castañón J; Moreno R; Reguillo F; Gil M; Picazo J; Sánchez-Harguindey L
    Int J Cardiol; 2003 Aug; 90(2-3):297-302. PubMed ID: 12957765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Link between intracellular pathogens and cardiovascular diseases.
    Gurfinkel E
    Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S33-S36. PubMed ID: 11869268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.
    Jackson LA; Campbell LA; Schmidt RA; Kuo CC; Cappuccio AL; Lee MJ; Grayston JT
    Am J Pathol; 1997 May; 150(5):1785-90. PubMed ID: 9137101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity.
    Fryer RH; Schwobe EP; Woods ML; Rodgers GM
    J Investig Med; 1997 Apr; 45(4):168-74. PubMed ID: 9154297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.
    Maass M; Bartels C; Engel PM; Mamat U; Sievers HH
    J Am Coll Cardiol; 1998 Mar; 31(4):827-32. PubMed ID: 9525555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern.
    Jha HC; Vardhan H; Gupta R; Varma R; Prasad J; Mittal A
    BMC Infect Dis; 2007 May; 7():48. PubMed ID: 17537253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery.
    Loehe F; Bittmann I; Weilbach C; Lauterjung L; Schildberg FW; Heiss MM
    Ann Vasc Surg; 2002 Jul; 16(4):467-73. PubMed ID: 12098020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque.
    Thomas M; Wong Y; Thomas D; Ajaz M; Tsang V; Gallagher PJ; Ward ME
    Circulation; 1999 Jun; 99(21):2733-6. PubMed ID: 10351965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlamydia pneumoniae and cardiovascular disease.
    Campbell LA; Kuo CC; Grayston JT
    Emerg Infect Dis; 1998; 4(4):571-9. PubMed ID: 9866733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia pneumoniae and atherosclerosis--an update.
    Saikku P
    Scand J Infect Dis Suppl; 1997; 104():53-6. PubMed ID: 9259083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.